• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

季节对食管癌切除术后老年食管鳞状细胞癌患者的影响:一项倾向评分匹配分析

Impact of seasons on elderly patients with esophageal squamous cell carcinoma following esophagectomy: a propensity score matching analysis.

作者信息

Li Kexun, Lu Simiao, Li Changding, Mao Jie, Zhang Huan, Wang Kangning, Liu Guangyuan, Huang Yunchao, Han Yongtao, Leng Xuefeng, Peng Lin

机构信息

Department of Thoracic Surgery, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu. No. 55, Section 4, South Renmin Road, Chengdu, 610041, Sichuan, China.

Department of Thoracic Surgery I, Third Affiliated Hospital of Kunming Medical University (Yunnan Cancer Hospital, Yunnan Cancer Center), Kunming, China.

出版信息

Discov Oncol. 2025 Jun 23;16(1):1182. doi: 10.1007/s12672-025-03009-w.

DOI:10.1007/s12672-025-03009-w
PMID:40549061
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12185820/
Abstract

BACKGROUND

Esophageal squamous cell carcinoma (ESCC) is prevalent in East Asia, with elderly patients facing unique postoperative challenges. This study examines the impact of seasonal variations on postoperative complications and survival in elderly patients undergoing esophagectomy for ESCC.

METHODS

This retrospective cohort study was conducted using data from the Sichuan Cancer Hospital & Institute Esophageal Cancer Case Management Database. Elderly patients (≥ 70 years) with thoracic ESCC who underwent esophagectomy between May 2016 and August 2021 were included. Patients were stratified into four seasonal groups: Winter (December-February), Spring (March-May), Summer (June-August), and Autumn (September-November). Primary outcomes included overall survival (OS), disease-free survival (DFS). Secondary outcomes assessed postoperative complications using the Clavien-Dindo classification.

RESULTS

A total of 469 elderly ESCC patients were included. The median overall survival was 51.6 months, with no significant differences in OS or DFS across the four seasonal groups. Restricted Mean Survival Time (RMST) and Restricted Mean Disease-Free Survival Time (RMDFST) analyses also showed no significant seasonal variations. The Summer group had a significantly higher incidence of hydrothorax compared to other groups (p < 0.05).

CONCLUSIONS

Seasonal variations influence specific short-term postoperative complications but do not significantly impact long-term survival in elderly ESCC patients undergoing esophagectomy.

摘要

背景

食管鳞状细胞癌(ESCC)在东亚地区较为普遍,老年患者术后面临独特挑战。本研究探讨了季节变化对接受ESCC食管切除术的老年患者术后并发症和生存的影响。

方法

本回顾性队列研究使用了四川省肿瘤医院&研究所食管癌病例管理数据库的数据。纳入2016年5月至2021年8月期间接受食管切除术的老年胸段ESCC患者(≥70岁)。患者被分为四个季节组:冬季(12月至2月)、春季(3月至5月)、夏季(6月至8月)和秋季(9月至11月)。主要结局包括总生存期(OS)、无病生存期(DFS)。次要结局使用Clavien-Dindo分类评估术后并发症。

结果

共纳入469例老年ESCC患者。中位总生存期为51.6个月,四个季节组的OS或DFS无显著差异。受限平均生存时间(RMST)和受限平均无病生存时间(RMDFST)分析也显示无显著季节差异。与其他组相比,夏季组胸腔积液的发生率显著更高(p<0.05)。

结论

季节变化影响特定的术后短期并发症,但对接受食管切除术的老年ESCC患者的长期生存无显著影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f20/12185820/c6fb649a8b7c/12672_2025_3009_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f20/12185820/f13e985d0362/12672_2025_3009_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f20/12185820/b3a270dfc001/12672_2025_3009_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f20/12185820/ac4d67a4e916/12672_2025_3009_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f20/12185820/658259f11b77/12672_2025_3009_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f20/12185820/afd9d1f25eae/12672_2025_3009_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f20/12185820/81b7fd6f7792/12672_2025_3009_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f20/12185820/c6fb649a8b7c/12672_2025_3009_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f20/12185820/f13e985d0362/12672_2025_3009_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f20/12185820/b3a270dfc001/12672_2025_3009_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f20/12185820/ac4d67a4e916/12672_2025_3009_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f20/12185820/658259f11b77/12672_2025_3009_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f20/12185820/afd9d1f25eae/12672_2025_3009_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f20/12185820/81b7fd6f7792/12672_2025_3009_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f20/12185820/c6fb649a8b7c/12672_2025_3009_Fig7_HTML.jpg

相似文献

1
Impact of seasons on elderly patients with esophageal squamous cell carcinoma following esophagectomy: a propensity score matching analysis.季节对食管癌切除术后老年食管鳞状细胞癌患者的影响:一项倾向评分匹配分析
Discov Oncol. 2025 Jun 23;16(1):1182. doi: 10.1007/s12672-025-03009-w.
2
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
3
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
4
The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation.伊立替康、奥沙利铂和雷替曲塞用于治疗晚期结直肠癌:系统评价与经济学评估
Health Technol Assess. 2008 May;12(15):iii-ix, xi-162. doi: 10.3310/hta12150.
5
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
6
Impact of perineural invasion in thoracic esophageal squamous cell carcinoma-a retrospective study with long-term follow-up outcomes.胸段食管鳞状细胞癌中神经周围侵犯的影响——一项具有长期随访结果的回顾性研究
J Thorac Dis. 2025 May 30;17(5):2989-3003. doi: 10.21037/jtd-2024-2043. Epub 2025 May 28.
7
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
8
Chemoradiotherapy versus chemoradiotherapy plus surgery for esophageal cancer.食管癌的化疗放疗与化疗放疗联合手术治疗对比
Cochrane Database Syst Rev. 2017 Aug 22;8(8):CD010511. doi: 10.1002/14651858.CD010511.pub2.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
10
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.静脉注射硫酸镁和索他洛尔预防冠状动脉搭桥术后房颤:系统评价与经济学评估
Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280.

本文引用的文献

1
Cancer incidence and mortality in China, 2022.2022年中国癌症发病率与死亡率
J Natl Cancer Cent. 2024 Feb 2;4(1):47-53. doi: 10.1016/j.jncc.2024.01.006. eCollection 2024 Mar.
2
Neoadjuvant chemotherapy with or without camrelizumab in resectable esophageal squamous cell carcinoma: the randomized phase 3 ESCORT-NEO/NCCES01 trial.可切除食管鳞癌新辅助化疗加或不加卡瑞利珠单抗的随机 III 期 ESCORT-NEO/NCCES01 试验。
Nat Med. 2024 Sep;30(9):2549-2557. doi: 10.1038/s41591-024-03064-w. Epub 2024 Jul 2.
3
Advances in diagnosis and management of cancer of the esophagus.
食管癌的诊断与治疗进展。
BMJ. 2024 Jun 3;385:e074962. doi: 10.1136/bmj-2023-074962.
4
Global epidemiology of early-onset upper gastrointestinal cancer: trend from the Global Burden of Disease Study 2019.全球早发性上消化道癌症的流行病学:2019 年全球疾病负担研究的趋势。
J Gastroenterol Hepatol. 2024 Sep;39(9):1856-1868. doi: 10.1111/jgh.16620. Epub 2024 May 21.
5
Challenges and considerations in interpreting the age-dependent benefit of neoadjuvant treatment for adenocarcinoma of the esophagus and gastroesophageal junction.解读食管癌和胃食管交界腺癌新辅助治疗的年龄依赖性获益中的挑战与考量
Int J Surg. 2024 Sep 1;110(9):5837-5840. doi: 10.1097/JS9.0000000000001606.
6
Surgical vs nonsurgical treatment for esophageal squamous cell carcinoma in patients older than 70 years: a propensity score matching analysis.70 岁以上食管鳞癌患者的手术与非手术治疗:倾向评分匹配分析。
J Gastrointest Surg. 2024 May;28(5):611-620. doi: 10.1016/j.gassur.2024.01.010. Epub 2024 Jan 23.
7
Neoadjuvant chemotherapy combined with immunotherapy versus neoadjuvant chemoradiotherapy in patients with locally advanced esophageal squamous cell carcinoma.新辅助化疗联合免疫疗法与新辅助放化疗治疗局部晚期食管鳞状细胞癌患者的疗效比较
J Thorac Cardiovasc Surg. 2024 Aug;168(2):417-428.e3. doi: 10.1016/j.jtcvs.2023.12.030. Epub 2024 Jan 19.
8
Perioperative toripalimab and chemotherapy in locally advanced gastric or gastro-esophageal junction cancer: a randomized phase 2 trial.围手术期特瑞普利单抗联合化疗治疗局部进展期胃或胃食管结合部腺癌的随机 2 期临床试验。
Nat Med. 2024 Feb;30(2):552-559. doi: 10.1038/s41591-023-02721-w. Epub 2024 Jan 2.
9
Age-dependent benefit of neoadjuvant treatment in adenocarcinoma of the esophagus and gastroesophageal junction: a multicenter retrospective observational study of young versus old patients.年龄依赖性新辅助治疗在食管胃交界腺癌中的获益:一项比较年轻患者与老年患者的多中心回顾性观察性研究。
Int J Surg. 2023 Dec 1;109(12):3804-3814. doi: 10.1097/JS9.0000000000000713.
10
Secular trends and attributable risk factors of esophageal cancer deaths among non-elderly adults based on Global Burden of Disease Study.基于全球疾病负担研究的非老年成年人食管癌死亡的长期趋势和可归因危险因素。
J Cancer Res Clin Oncol. 2023 Dec;149(18):16417-16427. doi: 10.1007/s00432-023-05380-z. Epub 2023 Sep 14.